The GLP1R rs6923761 variant, one of 150+ genetic insights mapped by PlexusDx, affects receptor sensitivity in your stomach and intestines
Clinical studies show semaglutide maintains consistent therapeutic levels for approximately seven days after injection
21 MASH is a disease closely associated with interconnected cardiovascular, renal and metabolic conditions, 22,23 and it is estimated that 34% of people living with obesity also have MASH
however, levels can drop by up to 90% (100 mmHg to 10 mmHg) in wound beds due to prolonged periods of poor blood perfusion 4
In the phase 2 clinical trial of Eli Lillys retatrutide, the drug showed a notable weight reduction effect, with an average of 17.5% loss in body weight over a 24-week period
Medication adherence and injection technique matter too